Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritalin for Glycemia and Apathy in Diabetics with Alzheimer's
NCT00792662Phase 4Withdrawn
- Sponsor
- University of Nebraska
- Start
- Nov 2008
- Primary completion
- Dec 2011
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in apathy, sponsored by University of Nebraska. Primary endpoint: Hemoglobin A1C at 16 weeks. Planned start Nov 2008; status: withdrawn.
02
Drugs
methylphenidate
03
Conditions
apathy
Beyond the preview
Go deeper on NCT00792662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792662.